Saatja: Vivian Saarpere <
[email protected]>
Saaja: SM Info
Teema: Valgevenes, Minskis korraldavast ravimialasest konsultatsioonidest 20-22-11.2018
Tere
Edastame tervishoiu ja töövaldkonna suunale Eesti saatkonnale Minskis edastatud informatsiooni Minskis 20-22. novembril toimuvatele ravimialasele konsultatsioonidele. Palume teie kaasabi selle info edastamisel asjast huvitatud instantsidele.
Lugupidamisega
Vivian Saarpere
Mobiil +375445906911
E-post
[email protected]<mailto:
[email protected]>
Telefon +375172177061
EV suursaatkond Minskis
[email protected]<mailto:
[email protected]>
koduleht: http:// www.estemb.by/
Välisministeeriumi koduleht: http://www.vm.ee/
Eastern Europe and Central Asia (EECA) Second Regional Consultation on
Expanding Access to Affordable and Quality Assured Medicines and
Diagnostic Technologies
Date: 20-22 November 2018
Venue: Marriott Hotel Minsk, Pobediteley ave., 20, “Falcon” conference hall
Tentative Agenda
Day 1, 20 November
08:30 – 09:00 Registration of participants
Conference floor lobby
09:00 – 09:15 Welcoming remarks Belarus Minister of Health (TBC)
UN Resident Coordinator in Belarus
Objectives of the meeting UNAIDS
SESSION I: Alignment of national guidelines as a way to increase access to quality affordable medicines
and diagnostic technology
Chair, facilitator: TBC
09:15– 09:30 HIV treatment optimisation and acceleration of WHO/Europe
Test & Treat strategy
09:30 - 09:45 Simplified treatment of HCV and use of WHO Europe or WHO HQ
pangenotypic regimens
09:45 -10:00 Roll out of new TB medicines Stop TB Partnership/Global Drug Facility
10:00 -10:20 HIV, TB and viral hepatitis diagnostic technology UNITAID
landscape (including polyvalent testing platforms)
10:20 -10:35 Q&As
10:35-11:05 Coffee Break
SESSION II: Using the regulatory framework as a way to increase access to quality affordable drugs
Chair, facilitator: TBC
11:05 - 11:20 Overview of legal and regulatory frameworks ITPCru
for antiretroviral and viral hepatitis treatment in
Eastern Europe and Central Asia
11:20 – 11:35 Regulatory environment for TB medicines in Stop TB Partnership
Eastern Europe and Central Asia
11:35 - 11:50 Public health-oriented licensing Esteban Burrone (TBC), Medicines Patent
Pool
11:50 – 12:20 Collaborative Registration: key principles and WHO EURO,
processes Dr Olexandr Polishchuk
Price comparison of first line anti-TB medicines
12:20 – 13:20 Country examples for fast-tracking registration or Belarus
adjusting packaging regulations Uzbekistan
Turkmenistan
Armenia
Azerbaijan
13:20 – 13:30 Q&As
13:30 – 14:30 Lunch
SESSION III: Chair, facilitator: TBC
14:30 – 15:45 What can we learn from the last 3 years of UNICEF
procurement experiences to inform strategic
procurement of ARVs to reach 90-90-90 in
EECA?
15:45 – 16:00 MSF
16:00 – 16:10 Q&As
SESSION IV: Access security to quality assured medicines
Chair, facilitator: TBC
16:10 – 16:30 Overview of WHO Prequalification program WHO EURO,
TB medicines in focus Dr Olexandr Polishchuk
16:30 – 17:00 Ukraine, Georgia: country case study on key MOH of Ukraine
benefits and challenges of the registration through Petro Golodyuk (TBD)
the WHO Collaborative Registration Process State Expert Centre
Georgia Medicines regulatory agency
17:00 – 17:10 Q&As
17:10 - 17:30 Coffee Break
National regulations
17:30 - 17:45 NRA assessment & Benchmarking: case study WHO EURO, Dorina Pirgari
from EECA countries Consultant
17:45- 18:00 Q&As
1
18:00 – 18:30 Closeout remarks/summary of the day Representative of the Ministry of Health
19:30 Dinner/reception
Day 2, 21 November
08:30 – 09:00 Registration of participants
Conference floor lobby
Session IV: Accessing international procurement mechanisms as a way to increase access to quality
affordable drugs (challenges and opportunities)
Chair, facilitator: TBC
09:00 – 10:10 Panel Discussion: Facilitator/s
Kazakhstan using (State procurements
through UNICEF (ARV) and UNDP
(HCV)
Georgia (State procurements through GF
PR/wambo)
Belarus
Moldova
Turkmenistan using (State procurements
through UNDP)
Ukraine (Amendment of legislation to
allow international procurement)
Republic of Armenia (Amendment of
legislation to allow international
procurement)
10:10 – 10:30 Q&As
10:30 – 11:00 Panel Discussion: Facilitator/s
Procurements after graduation from GF;
Challenges with ensuring access to affordable
quality TB and HIV medicines transitioning from
GF
Estonia
Latvia
Lithuania
Poland
Kyrgyzstan
Tajikistan
Armenia
Moldova
11:15 - 11:30 Q&As
11:30 -12:00 Coffee Break
2
SESSION V: Moving forward: Regional plans/roadmap and coordination platform
Chair: Ministry of Health of Belarus
Facilitators:
(someone to draft instructions)
12:00 - 13:30 Group work – 3 groups to work on the following Available Plenary hall + 3 small rooms
topics (30 min per group)
Flipcharts or whiteboards are needed
1. Regulatory environment
2. Drug registration The session will be facilitated by all partners
3. Price reduction, including TRIPS involved in the meeting
13:30 – 14:30 Lunch
14:30 – 16:00 Plenary discussion
16:00 - 16:30 Coffee Break
Joint Statement on expanded access to affordable and quality assured medicines and diagnostic technologies
in Eastern Europe and Central Asia
16:30-17:30 Presentation of draft Joint Statement on expanded Representative of the Ministry of Health
access to affordable and quality assured medicines Facilitators
and diagnostic technologies in EECA
Plenary discussion -feedback, comments on the
Statement
17:30 -18:00 Closeout remarks/summary of the day Representative of the Ministry of Health
19:00 Dinner
Eastern Europe and Central Asia (EECA) Second Regional Consultation on
Expanding Access to Affordable and Quality Assured Medicines and Diagnostic
Technologies
Date: 22 November 2018
Venue: Marriott Hotel Minsk, Pobediteley ave., 20, “Falcon” conference hall
Tentative Agenda
07:45 – 08:30 Registration of participants
3
Conference floor lobby (second floor)
Facilitator: Svetlana Borovskaya, UNAIDS Goodwill Ambassador in Belarus?
08:30 - 08:45 Welcoming remarks Minister of Health of Belarus
08:45 - 09:00 Address from Belarusian Government Vice-prime minister (TBC)
09:00-09:30 Welcoming remarks UNAIDS
GF
WHO
Stop TB Partnership
09:30 – 09:40 Summary of the technical meeting Speaker TBC
09:40 - 10:20 Panel and plenary discussion: Panel:
International support for sustainable access UNAIDS
to affordable quality assured drugs and Global Fund
advanced diagnostic technologies WHO EURO, Hans Kluge
Stop TB, Lucica Ditiu
UNICEF (Experience from working with
countries that graduated from GAVI)
10:20 - 10:35 Presentation and adoption of the Joint Ministry of Health
Statement on expanded access to
affordable and quality assured medicines
and diagnostic technologies in EECA
10:35 -10:50 Joint Statement signing ceremony Facilitator: Svetlana Borovskaya, UNAIDS
Goodwill Ambassador in Belarus?
10:50-11:20 Coffee-break
Press conference
Facilitators:
11:20-11:35 Presentation:
HIV, TB and Viral Hepatitis epidemics and Dr Mariângela Batista Galvão Simão, Assistant
access to medicines in EECA in line with Director-General for Drug Access, Vaccines and
Global Plans and key recommendations Pharmaceuticals TBC
from the UN SG High Level Panel on
Access to Medicines
11:35-12:35 Panel discussion: Opportunities, challenges People+, ITPCru, MSF, TB Europe coalition,
and prospect for sustainable access to Eurasian Women's Network on AIDS, All-
4
affordable quality assured drugs and Ukrainian network of PLHIV
diagnostic technologies – Patient and
community perspectives
12:35-12:50 Q&As
12:50-13:50 Panel Discussion: MoH representatives of:
Towards ending HIV, TB and viral hepatitis Republic of Azerbaijan
as a public health threat: translating new Georgia
momentum into concrete results Republic of Moldova
(10’per country) Republic of Tajikistan
Ukraine
Republic of Uzbekistan
13:50 - 15:00 Group Photo
Lunch
Facilitators:
15:00 – 16:00 Panel Discussion: MoH representatives of:
Towards ending HIV, TB and viral hepatitis Republic of Armenia
as a public health threat: translating new Republic of Belarus
momentum into concrete results (10’ per Republic of Kazakhstan
country) Kyrgyz Republic
Russian Federation
Turkmenistan
16:00 - 16:30 Plenary discussion - to sum up all the key Moderator:
outcomes from the meeting and give
possibility to those who did not have special
slot in the agenda to speak
16:30 - 17:00 Coffee Break
17:00 – 17:30 Closing remarks Ministry of Health of Belarus
20-22 November 2018. To arrange different booths in the lobby: TA booth, where countries can come and request
a TA identified during the meeting, GDF booth, where countries can discuss the collaboration, UNICEF booth (the
same as for GDF etc), Global fund booth (presenting Wamboo or pooled procurement mechanism), MSF booth,
PFSCM, etc
5
( -l]i {i/f .Ч.\ ll
J
ф t/"r'T<"r"rl,Xr- ф %rn-rr*
in, t}w, 7<ч"rlrlr- ф Z r,t **
J\ъ СiЁ-& в /Sоэ
The Embassy of the Republic of Веlаrus in the Republic of Estonia
presents its compliments to the Ministry оf Social Affairs of the Republic of
Estonia and has the honour to forward the invitation to the 2"d Regional
Consultation оп Expanding Access to Affordable and Quality Assured
medicines and diagnostic technologies.
The Embassy avails itself of this opportunity to renew to the Ministry the
assurances of its highest consideration.
3,2018
to the Ministry of Social Affairs
of the Republic of Estonia
Tallinn
ъ \.I
MINISTRY ОF HEALTH
ОF ТНЕ REPUBLIC
ffi МИНИСТЕРСТВО
ЗДРАВООХРАНЕНИЯ
ОF BELARUS РЕСПУБЛИКИ БЕЛАРУСЬ
220048, Minslq 39 Myasnikova Srгеееt Ул.Мясникова, 39, 22004В, г.Минск
Рhопе : +3 75 l 7 -?22-65 -47, Fм: +] 7 5 1 7-222 -46-2'1 Тел. +37517 Z22 65 47, факс +З7517 22? 462J
http ;//m i п zdlav €o_y, Ьу/еп Е-mаi l : mzrЬ @Ье l cml Ьу htгп ://minzdral,,gov.b]zlrц E-maiI: mzrb(@beIcmt.by
еl,а?аа/t tt j9 €//ёщ
На Ns
Ms. Riina Sikkut
Minister of Health and Labour
of the Republic of Estonia
Ministry of Social Affairs
Suur-Аmееrikа 1
|ап2 Tallinn, Estonia
Dear Minister,
Оп behalf of the organizers of the Еаstеrп Еurоре and СепtrаI Asia
(ЕЕСА) Znd Regional Consultation оп Expanding Aocess to Affordable and
Quality Assured medicines and diagnostic technologies it is mу hопоur to
invite you to participate in this eyent whioh will Ье held in Minsk, Belarus,
оп 20-22 November 20 1 8 .
The Consultation is hosted Ьу the Ministry of Health of the Republic of
Belarus with organizational suрроrt Ьу the Joint United Nations Рrоgrаmmе
on HIV/AIDS (LINAIDS), the Global Fuпd to Fight AIDS, ТuЬеrсulоsis and
Malaria, the World Health Organization and the Stop ТВ Раrtпеrshiр.
Participants at the Regional СопsulИtiоп will include the Ministers of
Health, medioines supply poiicy makers апd regulators оf рhаrгпасеutiсаl
sector frоm the 12 ЕЕСА countries: Аrmепiа, Azerbaijan, Belarus, Georgia,
Kazakhstan, Kyrgyzstan, Moldova, Russian Fеdеrаtiоп, Tajikistan,
Turkmenistan, Ukraine arrd Uzbekistan, representatives of Lithuania, Latvia
and Estonia, representatives of the international organizations, key раrtпеrs,
relevant experts, representatives of
the pharmaceutical companies,
intemational рrосчrеmепt agents and mеmЬеrs of civil socieý.
We аrе delighted to invite you to represent уочr country at the Regional
Consultation and соuпt оп уочr participation оп 22 NочеrпЬеr 2018 - the
hiф_lечеl segment of the meeting. То present the experience of Poland in
medicines supply policy and regulations of pharmaceutical sесtоr during the
technical раrt of the consulИtion that will take рlасе оп20-21 NочеmЬеr we
kindly request уоu to nominate а specialist responsible for these issues in the
ministry.
The drаft Concept note is enclosed for уочr iпfоrmаtiоп. All fuПhеr
documents will Ье sent directly to уоu well iп аdчапсе. The offioial
languages of the event will Ье Russian and English.
We sincerely hope that you will Ье able to accept оur inviИtion and
would Ье grateful to гесеiче уочr confirmation together with the паmе of
nominated specialist Ьуl8 ОсtоЬеr 2018 to the Ministry of Health of the
Republio of Belarus Ьу е-mаil; ооцfmiпsk@Ьеlсmt.Ьу, Fоr morе iпfогmаtiоп
please contact LINAIDS Country office in Belarus чiа tel.: +375 |72202461
оr emai1:
[email protected],
We look forward to welcoming you to Minsk in November.
Yоurs sincerely,
Minister of Health
оf the Republic of Belarus Иана Vаlеry Malashko
E}{CL (1)
Saatja: Embassy of Belarus <
[email protected]>
Saaja: SM Info
Teema: Fwd: letter from the Embassy of the Republic of Belarus
Dear ladies and gentlemen,
I will be pleased for the information about the participation of the Estonian side in the 2nd Regional Consultation on Expanding Access to Affordable and Quality Assured medicines and diagnostic technologies.
--
Best regards,
Yury Bulavko
Counsellor of the Embassy of Belarus
tel + 372 651 55 00
fax + 372 655 80 01
-------- Перенаправленное сообщение --------
Тема: letter from the Embassy of the Republic of Belarus
Дата: Wed, 3 Oct 2018 15:54:26 +0300
От: Embassy of Belarus <
[email protected]><mailto:
[email protected]>
Кому:
[email protected]<mailto:
[email protected]>
letter from the Embassy of the Republic of Belarus
--
Best regards,
Yury Bulavko
Counsellor of the Embassy of Belarus
tel + 372 651 55 00
fax + 372 655 80 01
Eastern Europe and Central Asia (EECA) Second Regional Consultation on
Expanding Access to Affordable and Quality Assured Medicines and
Diagnostic Technologies
20-22 November 2018
Minsk, Belarus
Background
The Eastern Europe and central Asia region remains home to the fastest growing HIV infection and
the highest levels of multidrug resistant (MDR) TB in the world. The estimated 323 000 incident TB
cases in the Region include 27 000 cases (8.4%) with HIV co-infection. The main contributor to the
development of resistant TB is mal-treated susceptible TB. The Region represents almost 20% of
the total global hepatitis C virus (HCV) antibody-positive population and account for the largest
proportion of HIV-infected persons who have serological evidence of past or present HCV infection.
Over the last ten years, the EECA region have made significant strides to increase the number of
people who know their HIV, TB, and viral hepatitis status and receive treatment, however these
have not translated into any significant increase in regional coverage, figuring itself among the
lowest in the world. Expanding ART eligibility based on World Health Organization (WHO) new
recommendations “test and treat” had significant cost implications for the HIV response in all
countries of the region. Yet overall, the region continues to pay high prices for ARV therapy, while
at the same time providing some of the lowest coverage of people on treatment. The EECA is also
the most affected region by drug resistant TB, especially multidrug resistant TB globally with a
huge economic impact due to the high cost of second line drugs regimens and big challenges in
ensuring access and scale up – with just a very small fraction of people in need being currently
diagnosed and treated. The uptake of the new Antituberculosis medicines and new regimens is
extremely slow and with limited availability. The current WHO guidelines recommend offering
curative treatment with Direct Acting Antivirals (DAAs) to all persons infected with HCV. The cost
of DAAs decreased dramatically in the last few years, especially in countries where generic DAAs
are available (in some countries the price of 3-months curative treatment course decreased 1000-
fold comparing to the initial price for branded medicines), and many countries have substantially
increased access to treatment and started large scale treatment programmes. Still, low coverage
of diagnosis, also due to high cost of diagnostics and lack of optimization of viral hepatitis
diagnostic pathway, represents a major barrier towards achieving the global goal of elimination of
viral hepatitis as a public health threat by 2030. Given the significant burden of disease due to TB,
HIV and viral hepatitis, including co-infections, and low treatment coverage, EECA countries need
to ensure early diagnosis and availability of quality assured medicines at affordable prices to
expand treatment coverage and prevent the onward transmission of HIV, TB and viral hepatitis.
1
The first Regional Consultation on Expanding Access to Affordable and Quality Assured
Antiretroviral and Antituberculosis medicines took place on 2-3 November 2016 in Minsk, Republic
of Belarus. The Regional Consultation was hosted by the Ministry of Health of the Republic of
Belarus with organizational support of the Joint United Nations Programme on HIV/AIDS (UNAIDS),
the Global Fund to Find AIDS, Tuberculosis and Malaria (GFATM), and the Stop TB Partnership. The
Consultation brought together Ministers of Health, medicines supply policy makers and regulators
of pharmaceutical sector from twelve EECA countries, as well as representatives of international
organizations, experts, representatives of pharmaceutical companies and civil society and
community activists. The meeting resulted in a joint declaration on expanded and rapidly scaled up
access to affordable quality assured ARV and TB medicines in EECA – Minsk Statement of the
Ministries of Health of Eastern Europe and Central Asia “HIV and Tuberculosis: Treatment for All”.
(Annex 1)
To discuss the progress made and challenges in implementation of the Minsk Statement, the
follow-up meeting is planned in November 2018 in Minsk, Belarus.
Scope and Format
The second Regional Consultation planned for 20-22 November 2018 in Minsk is to be hosted by
the Ministry of Health of the Republic of Belarus with organizational support by the UNAIDS,
GFATM, WHO, and the Stop TB Partnership. The Consultation will get together the Ministers of
Health, medicines supply policy makers and regulators of pharmaceutical sector from Armenia,
Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Republic of Moldova, Russian Federation,
Tajikistan, Turkmenistan, Ukraine and Uzbekistan, as well as representatives of international
organizations, key partners, relevant experts, representatives of the pharmaceutical companies,
procurement agencies and members of civil society.
The meeting will consist of two parts – technical consultation to be held from November 20th to
November 21st and a high-level meeting planned for November 22nd.
The participants of the technical consultation will discuss the progress made and challenges in
implementation of Minsk Statement 2016 as well as innovative strategies, actions and
opportunities for ensuring long-term access of EECA countries to quality assured medicines and
diagnostic technologies for HIV, TB and viral hepatitis at affordable prices and increasingly funded
with domestic resources.
The high-level meeting will take place under the leadership of the Ministers of Health of the
respective countries and with the engagement and support of the UNAIDS, GFATM, WHO Euro and
Stop TB Partnership to reach a political agreement and reinstate the commitments made at Minsk
meeting in 2016.
2
The main outcome of the Consultation will be signing of the Minsk II Statement on expanded access
to affordable and quality assured medicines and diagnostic technologies for HIV, TB and Hepatitis C
in Eastern Europe and Central Asia.
Objectives of the Regional Consultations
1. To adopt Minsk II Statement on expanded access to affordable and quality assured
medicines and diagnostic technologies for HIV, TB and viral hepatitis in EECA
2. To share experiences in HIV, multidrug resistant tuberculosis, Viral Hepatitis prevention and
treatment programmes’ implementation at country level including to provide to the
countries overview of the current price ranges in medicines and diagnostic technologies for
HIV, TB and Viral Hepatitis procured from domestic and international funds in the EECA
region
3. To discuss challenges and opportunities in implementation of Minsk I Statement
4. To present and discuss ARV, TB and viral hepatitis medicines and diagnostic market trends
and regional demand forecasts from 2018 to 2020 for adult and paediatric patients
5. To agree on policies to promote polyvalent testing platforms in community settings,
healthcare facilities, home testing with special attention to cost and cost-effectiveness and
the possibility of testing multiple diseases at the same time.
6. To present and discuss opportunities and bottlenecks for the public sector to procure
medicines and diagnostics on the international market at low cost (Global Fund Pooled
Procurement Mechanism and its online marketplace www.wambo.org, Stop TB partnership
GDF, UN agencies, International procurement agents, etc.)
7. To discuss/present instruments allowing accelerated registration of medicines in the
countries and achieve commitment to implement it.
8. To discuss the technical assistance required for countries to address existing legal,
programmatic and other constraints for procurement of quality assured medicines and
diagnostics technologies or for their local manufacture.
Expected Participants
Ministers of Health, national experts in HIV, TB and Hepatitis medicines procurement, experts
in drug registration and drug market regulation (Belarus, Russian Federation, Kyrgyzstan,
Kazakhstan, Armenia, Azerbaijan, Georgia, Republic of Moldova, Tajikistan, Turkmenistan,
Uzbekistan, Ukraine, Estonia, Latvia, Lithuania, Poland.
International organizations and partners (WHO, UNDP, UNICEF, UNAIDS, UNITAID, Global Fund,
Stop TB Partnership, MSF, MPP, Eurasian Patent Organization, The Partnership for Supply Chain
Management (PFSCM) and others.
3
Local, regional and International Civil society organizations (Médecins Sans Frontières (MSF),
the International Treatment Preparedness Coalition Russia (ITPCru), “East Europe and Central
Asia Union of People Living with HIV” (ECUO), TB Europe Coalition, "AGEP'C" Kazakhstan,
Alliance Public Health Ukraine, Eurasian Women's Network on AIDS, and others).
Representatives of the pharmaceutical industry.
4